Stay updated on ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page
- Check6 days agoChange DetectedThe study locations section has been reorganized and expanded to group sites under 'Locations' by U.S. states, Canadian provinces, and selected international regions (Chiba, Hokkaido, Miyagi, Osaka, Tokyo), and the revision version updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe Publications section now states that PubMed-sourced publications are auto-filled and may not all pertain to the study, and the revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe notice about government funding status (outlining NIH operations and potential delays) was removed from the page, reducing clutter without impacting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedComparison shows only minor formatting/layout updates and a revised last-updated timestamp on the Study Details page, with no changes to core study content, eligibility criteria, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange Detected- Added a government-operating-status notice and a link to official sources; - Updated software version from v3.1.0 to v3.2.0; - Removed the old version reference.SummaryDifference3%

- Check91 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.4%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.